Hostname: page-component-74656f9884-kv2lp Total loading time: 0 Render date: 2026-11-06T06:24:27.631Z Has data issue: false hasContentIssue false

Characterisation and use of OSLD for in vivo dosimetry in head and neck intensity-modulated radiation therapy

Published online by Cambridge University Press:  25 September 2020

L. Jose Solomon Raj
Affiliation:
Department of Radiation Oncology, Christian Medical College, Vellore, Tamil Nadu 632004, India
Benedicta Pearlin
Affiliation:
Department of Radiation Oncology, Christian Medical College, Vellore, Tamil Nadu 632004, India
B. S. Timothy Peace
Affiliation:
Department of Radiation Oncology, Christian Medical College, Vellore, Tamil Nadu 632004, India
Rajesh Isiah
Affiliation:
Department of Radiation Oncology, Christian Medical College, Vellore, Tamil Nadu 632004, India
I. Rabi Raja Singh*
Affiliation:
Department of Radiation Oncology, Christian Medical College, Vellore, Tamil Nadu 632004, India
*
Author for correspondence: I. Rabi Raja Singh, Professor in Radiological Physics, Department of Radiation Oncology, Christian Medical College, Vellore, Tamil Nadu 632004, India. Tel: +91 9443627672/+91 416 2283069. E-mail: rabiraja@cmcvellore.acin
Rights & Permissions [Opens in a new window]

Abstract

Aim:

This study reveals the characteristic nature and the use of optically stimulated luminescence dosimeters (OSLD) as an in vivo dosimetry tool for head and neck intensity-modulated radiation therapy (IMRT).

Materials and methods:

Calibration and characterisation of OSLD such as sensitivity, reproducibility, dose-rate dependence, beam quality dependence, output factor measurement and comparison of two bleaching techniques using halogen and compact fluorescent lamp (CFL) were initially performed. Later, eye dose measurements were performed for head and neck IMRT patients using OSLD and were compared with the corresponding dose calculated by the treatment planning system (TPS).

Results:

While the sensitivity was found to be within ±5%, the dose-rate dependence and reproducibility were found to be within ±3%. The OSLD showed an under-response of 3% for 15 MV and an increase in response by 5% for Co60 (1·25 MeV) when compared with the 6 MV X-ray beam. Therefore, a separate calibration for different beam energies is required. The percentage deviation of OSLD to that of TPS was found to be within ±2·77%. The OSLD has been successfully used for the in vivo dosimetry of patients who received IMRT. Hence, it is concluded that OSLDs can serve as effective dosimeters for in vivo dosimetry.

Information

Type
Original Article
Copyright
© The Author(s), 2020. Published by Cambridge University Press
Figure 0

Figure 1a. Active material outside the plastic case.

Figure 1

Figure 1b. Back view of nanoDot OSLD.

Figure 2

Figure 2. Readout process inside OSLD reader.

Figure 3

Figure 3. MicroStar nanoDot™ OSLD reader.

Figure 4

Figure 4. In-house build-up cap made of bee wax.

Figure 5

Figure 5. Setup diagram for sensitivity measurement of OSLD.

Figure 6

Figure 6. Calibration setup of OSLD in Clinac 2100C/D.

Figure 7

Figure 7. Bleaching of OSLD using halogen bulb (150 W).

Figure 8

Figure 8. Bleaching of OSLD using CFL bulb (15 W).

Figure 9

Figure 9. Response of OSLDs made similar after applying ICF.

Figure 10

Figure 10. Reproducibility of OSLDs.

Figure 11

Figure 11. Relative output factors for a 6 MV X-ray beam measured with OSLDs and 0·6 cc PTW ion chamber.

Figure 12

Figure 12. Energy dependence of OSLD with 6 MV as normalised value.

Figure 13

Figure 13. Dose-rate dependence of OSL detectors in a 6 MV linac beam where the response was normalised to the reading at a dose rate of 100 cGy/minute.

Figure 14

Figure 14. Normalised OSL signal versus increase in the dose (cGy) for 6 MV X-ray beam irradiation.

Figure 15

Figure 15. Comparison of OSL residual on different modalities of bleaching.

Figure 16

Table 1. In vivo dose measurement for five IMRT patients